Top of this page
Skip navigation, go straight to the content

ucb-usa.com Newsroom UCB U.S. News

Categories

  • UCB Hosts Wake County Teachers for STEM Immersion Program

    1280x960.wakeed

    Yesterday, July 19, UCB’s Research Triangle Park (RTP) office hosted ten high school teachers as part of WakeEd’s SummerSTEM immersion program. SummerSTEM is an award-winning, eight-day professional development program to enrich educators’ understanding of the knowledge and skills necessary to succeed in STEM (Science, Technology, Engineering, & Math) careers. This program is a collaboration between the WakeEd Partnership, the Wake County Public School System, and biotech businesses in North Carolina.

    Read more

  • Press Release: UCB Launches the Autoimmune Motherhood (AIM) Movement™ to Empower and Inform Women with Chronic Inflammatory Disease About Family Planning

    updated _1280UCB_SOCIAL_POST_TWITTER_071118_CLOCK

    The AIM Movement provides support, information and a place to share stories about motherhood in women with chronic inflammatory diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and Crohn’s disease (CD).

    Read more

  • Emergency Preparedness This Hurricane Season

    UCBCares_hurricane_1280x960

    June marked the beginning of the 2018 hurricane season. Natural disasters – like hurricanes—can hit anywhere, any time. For someone living with a chronic disease, preparing for a disaster goes beyond just securing life and property—one must consider how to maintain access to much needed medicines.

    Read more

  • UCB Innovator Joins PhRMA as Scholar at Aspen Ideas Festival

    Ideas3_1280x960

    Edward (Eddy) Han-Burgess was recently invited to attend the Aspen Ideas Festival Spotlight Health as a PhRMA Aspen Scholar. He joined four other emerging leaders from the biopharma industry from AstraZeneca, Eli Lilly and Company, Merck, and Novartis for a series of events on the new era of medicine and as a conference participant.

    Read more

  • UCB Supports Georgia Bio Ed Institute Biotech Immersion Program

    Biotech_Immersion_1280x960


    Earlier this month, UCB supported Georgia BioEd Institute’s Summer Biotech Immersion Program. The pilot program took place at Paulding County High School from June 4-8. Eight biology and biotechnology teachers from metro Atlanta area high schools attended the laboratory-intensive professional learning experience in Marc Pedersen’s classroom, 2017 Biology Teacher of the Year.

    Read more

  • “Mr. Researcher Goes to Washington” for GoBoldly

    Posted by

    Fly_in_pic_for_blog_1280x960





    L to R: Eddie Lee, Pharm.D., Robert Suruki, Sc.D., Ali Bozorg, M.D., Pamela Doty Braker, Ph.D., Stephen Yates, Ph.D.

    Last week, 55 U.S.-based biopharmaceutical researchers from 20 different companies headed to Capitol Hill to share their stories with members of the U.S. Congress as part of the 2018 Pharmaceutical Research and Manufacturers of America (PhRMA) GoBoldly Fly-In.

    Read more

  • UCB and Rebuilding Together Help Fragility Fracture Patient Stay at Home

    Marilyn_EDITED_1280x960

    Last month, UCB teamed up with Rebuilding Together®Silicon Valley, a non-profit organization committed to repairing homes for older Americans or people living with disabilities who are physically and financially unable to maintain safe living conditions.

    Read more

  • UCB @ BIO 2018

    Charl_at_BIO_1280x960

    We’re excited to be in Boston this week at the kickoff of the 25th 2018 BIO International Convention.

    Read more

  • Press Release: UCB Announces the Approval of CIMZIA® (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.

    Cimzia_1280x960_Logo

    • The U.S. Food and Drug Administration’s (FDA) approval of CIMZIA® (certolizumab pegol) for use in moderate-to-severe plaque psoriasis marks the entry of UCB into immuno-dermatology
    • CIMZIA Phase 3 psoriasis studies demonstrated significant and clinically meaningful improvements in biologic-naïve patients and those previously treated with biologics, with clinical benefit maintained through 48 weeks and the flexibility of two dose regimens that allow for tailored treatment1

    Read more

  • UCB Female Execs Lead GA Healthcare Industry Groups

    Female_Leaders_Photo_1280x960

    We are pleased to recognize two UCB leaders, Patty Fritz and Stephanie Hunter-Banks, who were recently appointed to leadership positions for Georgia healthcare industry groups: Georgia Bio and Healthcare Businesswomen’s Association (HBA), Atlanta Chapter, respectively. In support of our corporate strategy to create maximum value for patients, UCB is dedicated to encouraging diversity and inclusion. We are proud to celebrate the accomplishments of these two leaders who encourage and inspire the UCB colleagues around them.

    Read more